Exposing a Cancer Cell’s Weakness
MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Related Articles
| Memorial Sloan Kettering Cancer Center
The Rockefeller Outpatient Pavilion at 53rd Street is temporarily closed following an isolated fire in a non-clinical area on Sunday evening. The fire was quickly…
MSK Research Highlights July 17, 2023
New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a…
July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic…
July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic…
When a cancer drug trial has a 100% success rate, you want to know who’s behind it. (It’s Luis Diaz Jr.)
Oncologist Luis Diaz Jr., at Memorial Sloan Kettering, achieved a breakthrough in cancer treatment. He focused on tumors with MMR deficiency.
Food as Medicine: Why One Doctor Thinks Diet Could Help Control Cancer
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from…
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results – Nature Medicine
Prophylactic subcutaneous administration of anakinra, an IL-1 receptor inhibitor, reduced severe immune effector cell-associated neurotoxicity syndrome incidence in patients with relapsed or refractory large B-cell…
Food as Medicine: Why One Doctor Thinks Diet Could Help Control Cancer
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from…
Summer Pipeline Program
This eight-week research program offers students from underrepresented groups in medicine the opportunity to gain research experience under the mentorship of MSK faculty.
MSK Awards & Appointments June 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.